MEDOVEX CORP. 1,391,305 Units, each consisting of (i) One Share of Common Stock, $0.001 par value; andMedovex Corp. • December 9th, 2014 • Surgical & medical instruments & apparatus • New York
Company FiledDecember 9th, 2014 Industry JurisdictionMedovex Corp. , a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,391,305 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters a thirty (30) day option to purchase an aggregate of up to 208,695 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant (a “Series A Warrant”). Each Series A Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlying the Units (the “Shares”), the Series A Warrants’ and the shares
MEDOVEX, INC. 1,391,305 Units, each consisting of (i) One Share of Common Stock, $0.001 par value; (ii) One Series A Warrant to Purchase One Share of Common Stock, $0.001 par value; and (iii) One Series B Warrant to purchase one share of Common Stock,...Medovex Corp. • December 2nd, 2014 • Surgical & medical instruments & apparatus • New York
Company FiledDecember 2nd, 2014 Industry JurisdictionMedovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,391,305 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters a thirty (30) day option to purchase an aggregate of up to 208,695 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common
MEDOVEX, INC. 1,391,305 Units, each consisting of (i) One Share of Common Stock, $0.001 par value; (ii) One Series A Warrant to Purchase One Share of Common Stock, $0.001 par value; and (iii) One Series B Warrant to purchase one share of Common Stock,...Medovex Corp. • November 26th, 2014 • Surgical & medical instruments & apparatus • New York
Company FiledNovember 26th, 2014 Industry JurisdictionMedovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,391,305 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters a thirty (30) day option to purchase an aggregate of up to 208,695 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common
MEDOVEX, INC. 1,350,000 Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTMedovex Corp. • November 12th, 2014 • Surgical & medical instruments & apparatus • Florida
Company FiledNovember 12th, 2014 Industry JurisdictionMedovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,350,000 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to 202,500 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlyi
MEDOVEX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTMedovex Corp. • October 7th, 2014 • Surgical & medical instruments & apparatus • Florida
Company FiledOctober 7th, 2014 Industry JurisdictionMedovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock
MEDOVEX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTMedovex Corp. • July 8th, 2014 • Surgical & medical instruments & apparatus • Florida
Company FiledJuly 8th, 2014 Industry JurisdictionMedovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) and ______ Class B Warrants (the “Underwritten Series B Warrants”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) and ____ additional Series B Warrants (the “Additional Series B Warrants” and collectively, with Underwritten Series B Warrants the “Series B Warrants”) each as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant